Bisphosphonate-Associated Osteonecrosis of the Jaw
"Bisphosphonate-Associated Osteonecrosis of the Jaw" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Necrotic jaws or other maxillofacial skeleton necrosis associated with bisphosphonate use (see BISPHOSPHONATES). Injury, dental procedures, and trauma can trigger the necrotic process.
| Descriptor ID |
D059266
|
| MeSH Number(s) |
C05.116.852.087 C05.500.086 C07.320.086 C23.550.717.732.183
|
| Concept/Terms |
Bisphosphonate-Associated Osteonecrosis of the Jaw- Bisphosphonate-Associated Osteonecrosis of the Jaw
- Bisphosphonate Associated Osteonecrosis of the Jaw
- Bisphosphonate-Induced Osteonecrosis of the Jaw
- Bisphosphonate Induced Osteonecrosis of the Jaw
- Bisphosphonate-Induced Osteonecrosis of the Jaws
- Bisphosphonate Induced Osteonecrosis of the Jaws
- Bisphosphonate-Related Osteonecrosis of the Jaw
- Bisphosphonate Related Osteonecrosis of the Jaw
- Osteonecrosis of the Jaws, Bisphosphonate-Associated
- Osteonecrosis of the Jaws, Bisphosphonate Associated
- Osteonecrosis of the Jaw, Bisphosphonate-Related
- Osteonecrosis of the Jaw, Bisphosphonate Related
- Osteonecrosis of the Jaws, Bisphosphonate-Induced
- Osteonecrosis of the Jaws, Bisphosphonate Induced
- Osteonecrosis of the Jaws, Bisphosphonate-Related
- Osteonecrosis of the Jaws, Bisphosphonate Related
- Osteonecrosis of the Jaw, Bisphosphonate-Associated
- Osteonecrosis of the Jaw, Bisphosphonate Associated
- Bisphosphonate-Associated Osteonecrosis of the Jaws
- Bisphosphonate Associated Osteonecrosis of the Jaws
- Osteonecrosis of the Jaw, Bisphosphonate-Induced
- Osteonecrosis of the Jaw, Bisphosphonate Induced
Bisphosphonate-Associated Osteonecrosis- Bisphosphonate-Associated Osteonecrosis
- Bisphosphonate Associated Osteonecrosis
- Bisphosphonate-Associated Osteonecroses
- Osteonecroses, Bisphosphonate-Associated
- Osteonecrosis, Bisphosphonate-Associated
- Bisphosphonate Osteonecrosis
- Bisphosphonate Osteonecroses
- Osteonecroses, Bisphosphonate
- Osteonecrosis, Bisphosphonate
|
Below are MeSH descriptors whose meaning is more general than "Bisphosphonate-Associated Osteonecrosis of the Jaw".
Below are MeSH descriptors whose meaning is more specific than "Bisphosphonate-Associated Osteonecrosis of the Jaw".
This graph shows the total number of publications written about "Bisphosphonate-Associated Osteonecrosis of the Jaw" by people in this website by year, and whether "Bisphosphonate-Associated Osteonecrosis of the Jaw" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bisphosphonate-Associated Osteonecrosis of the Jaw" by people in Profiles.
-
Cho J, Feldman G, Tomlinson R, Taub D, Diecidue R. Medication-related osteonecrosis of the jaw (MRONJ) systemic review: mevalonate pathway mechanisms explored. Oral Surg Oral Med Oral Pathol Oral Radiol. 2024 10; 138(4):475-483.
-
Sweeny L, Long SM, Pipkorn P, Wax MK, Thomas CM, Curry JM, Yang S, Lander D, Chowdhury F, Amin D, Kane AC, Miles BA, Salama A, Cannady SB, Tasche K, Mann D, Jackson R. Microvascular reconstruction of medication related osteonecrosis of the head and neck. Head Neck. 2024 08; 46(8):1902-1912.
-
Sweeny L, Mayland E, Swendseid BP, Curry JM, Kejner AE, Thomas CM, Kain JJ, Cannady SB, Tasche K, Rosenthal EL, DiLeo M, Luginbuhl AJ, Theeuwen H, Sarwary JR, Petrisor D, Wax MK. Microvascular Reconstruction of Osteonecrosis: Assessment of Long-term Quality of Life. Otolaryngol Head Neck Surg. 2021 11; 165(5):636-646.
-
Saad F, Shore N, Van Poppel H, Rathkopf DE, Smith MR, de Bono JS, Logothetis CJ, de Souza P, Fizazi K, Mulders PF, Mainwaring P, Hainsworth JD, Beer TM, North S, Fradet Y, Griffin TA, De Porre P, Londhe A, Kheoh T, Small EJ, Scher HI, Molina A, Ryan CJ. Impact of bone-targeted therapies in chemotherapy-na?ve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: post hoc analysis of study COU-AA-302. Eur Urol. 2015 Oct; 68(4):570-7.
-
Saad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck AT, Diel IJ, Takahashi S, Shore N, Henry DH, Barrios CH, Facon T, Senecal F, Fizazi K, Zhou L, Daniels A, Carri?re P, Dansey R. Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol. 2012 May; 23(5):1341-1347.